See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Agilect, Azilect
Generic Name: Rasagiline
What is Rasagiline? Rasagiline is a MAO inhibitor which can enhance the activity of dopamine at the synapse. It is sometimes used in early Parkinson's as a monotherapy to enhance naturally existing levels of dopamine, or may be added on as an "adjunct" to other drugs in later stages.
See more information, including instructions, precautions, side effects, and interactions.
246 patients in the community are taking or have taken Rasagiline.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Treat Parkinson's | 192 | 82% |
| Other | 17 | 7% |
| Stiffness/spasticity | 12 | 5% |
| disease-related symptoms | 3 | 1% |
| Anxiety | 2 | <1% |
| Freezing of gait | 1 | <1% |
| Balance issues | 1 | <1% |
| Slowness | 1 | <1% |
| Memory problems | 1 | <1% |
| Excess saliva | 1 | <1% |
| Fatigue | 1 | <1% |
| Don't know | 1 | <1% |
How long current patients have been taking Rasagiline or how long patients were taking Rasagiline before stopping.
Results from 11 patient evaluations. See the overall results and all individual evaluations.
| Major | 33% | 3 |
|---|---|---|
| Moderate | 33% | 3 |
| Slight | 33% | 3 |
Treat Parkinson's
| Severe | 0% | 0 |
|---|---|---|
| Moderate | 0% | 0 |
| Mild | 27% | 3 |
| None | 73% | 8 |
Top reported side-effects include: Frequent urination
Summary results are based on 11 individual responses. For more information, see overall results for Adherence, Burden and Cost.